Loading... Please wait...
Connecting to intelligent information in the electronic age.
Market Research Categories
- Advanced Materials
- Clean Technologies
- Biotechnology
- Business and Consumer Appliances
- Communications Technology
- Electronics and Semiconductors
- Industrial Supplies and Accessories
- Information Technology
- Medical Equipment and Supplies
- Nanotechnology
- Security
- Transportation Industry
- Asia Market
- European Market
- Other Research
- Upcoming Reports
New Publications
-
-
The Global Market for Advanced Airport Technologies USD $4,850.00
-
-
Indian DTH Market Forecast to 2012 USD $800.00
-
- Home
- Medical Equipment and Supplies
- Healthcare
- Medical Imaging Reagents and Analysis Tools
Medical Imaging Reagents and Analysis Tools
Summary
The goal in conducting Medical Imaging Reagents study is to provide an overview of the current and future characteristics of the global market for medical imaging. The key objective is to present a comprehensive analysis of the current market and its future direction as an important tool for the diagnosis of various diseases. This report explores present and future strategies within the imaging market, including reagents, equipment and systems used for imaging. The improvisation of the market, its setbacks and needs are discussed in this report. Comparisons, usage and the advantages and disadvantages of each imaging system are also discussed in this report.
A detailed analysis of the imaging industry structure has been conducted. This includes both the imaging reagents and the equipment used. Revenues are broken down by region. Sales figures are estimated for the 5 year period from 2009 through 2014. Applications for imaging are also discussed separately in the report, with emphasis on its usage in cardiovascular, oncology, gastrointestinal and central nervous system diseases. The report also covers significant patents and their allotment in each category.
Medical imaging has seen major advances in modern medicine.The “compact revolution” is changing the market of imaging systems. R&D spending, along with increasing competition, patent expiries, new technologies, and an international marketplace are sending the market in new directions. Although the industry did see some setbacks in 2008 due to the economic downturn, new advancements and the need for diagnosis through imaging are helping the market to grow. This study looks at many of the systems affected by these factors. Acquisition strategies and collaborations by companies are also covered in this report. This study also discusses the strength and weaknesses of each system/ technology in light of new technologies, growing competition, and changing customer needs.
This study contributes to the areas of market growth in diagnosis through imaging from the point of view of manufacturers and users. Analytical companies, physicians, the pharmaceutical and biopharmaceutical industries, hospitals and research institutes will find this study to be of interest. The scope of this study encompasses the imaging, diagnosing and medical markets. The report analyzes each market and its applications by its need for diagnosis through imaging, regulatory environment, technology involved, market projections, and market share. Technological issues include the latest trends and developments.
This Report:
- Examine the supporting products that have enhanced imaging at the chemical level (reagents and contrast media) and at the analysis level (software tools and image management)
- Provide market data for 2008 and 2009, and forecast the compound annual growth rate (CAGR) for the period 2009-2014
- Explain how existing medical imaging modalities such as magnetic resonance imaging (MRI), ultrasound, computed tomography (CT), and nuclear medicine are finding new applications through the development of specialized imaging reagents
- Assess the major medical applications, market players, recent patents, and emerging technologies in reagents, analysis, and image management
TABLE OF CONTENTS
Chapter- 1:
INTRODUCTION
|
STUDY OBJECTIVES |
1 |
|
REASONS FOR DOING THIS STUDY |
1 |
|
INTENDED AUDIENCE |
2 |
|
SCOPE OF THE STUDY |
2 |
|
METHODOLOGY |
2 |
|
INFORMATION SOURCES |
2 |
|
DISCLAIMER |
3 |
Chapter-2:
SUMMARY
|
SUMMARY |
4 |
|
SUMMARY TABLE GLOBAL REVENUE OF THE IMAGING MARKET (IMAGING REAGENTS AND SYSTEMS), THROUGH 2014 ($ MILLIONS) |
5 |
|
SUMMARY FIGURE GLOBAL REVENUE OF THE IMAGING MARKET (IMAGING REAGENTS AND SYSTEMS), 2007-2014 ($ MILLIONS) |
6 |
Chapter-3:
OVERVIEW
|
WHAT IS MEDICAL IMAGING |
7 |
|
HISTORY OF MEDICAL IMAGING |
7 |
|
TABLE 1 HISTORY OF MEDICAL IMAGING, 1895-1993 |
7 |
|
TYPES OF MEDICAL IMAGING |
8 |
|
X-RAY IMAGING |
8 |
|
Applications of X-ray in Medicine |
8 |
|
TABLE 2 ADVANTAGES AND DISADVANTAGES OF X-RAY IMAGING |
9 |
|
ULTRASOUND |
9 |
|
Applications of Ultrasound |
9 |
|
TABLE 3 ADVANTAGES AND DISADVANTAGES OF ULTRASOUND |
10 |
|
MAGNETIC RESONANCE IMAGING |
10 |
|
Applications of Magnetic Resonance Imaging |
11 |
|
TABLE 4 ADVANTAGES AND DISADVANTAGES OF MAGNETIC RESONANCE IMAGING |
11 |
|
COMPUTED TOMOGRAPHY |
12 |
|
Applications of Computed Tomography |
12 |
|
TABLE 5 ADVANTAGES AND DISADVANTAGES OF COMPUTED TOMOGRAPHY |
13 |
|
POSITRON EMISSION TOMOGRAPHY |
13 |
|
Applications of Positron Emission Tomography |
14 |
|
TABLE 6 ADVANTAGES AND DISADVANTAGES OF POSITRON EMISSION TOMOGRAPHY |
14 |
|
DIFFERENTIATION BETWEEN VARIOUS IMAGING TECHNIQUES |
15 |
|
TABLE 7 DIFFERENCES BETWEEN CT AND PET |
15 |
|
TABLE 8 DIFFERENCES BETWEEN CT AND MRI |
15 |
|
CONTRAST AGENTS OR IMAGING REAGENTS |
15 |
|
PROPERTIES OF AN IDEAL CONTRAST AGENT |
16 |
|
CLASSIFICATION OF CONTRAST AGENTS BASED ON THEIR PROPERTIES |
16 |
|
Positive Contrast Agents |
16 |
|
Barium |
16 |
|
Iodine-based Contrast Agents |
17 |
|
Negative Contrast Agents |
17 |
|
CLASSIFICATION OF CONTRAST AGENTS BASED ON THE TYPE OF IMAGING TECHNIQUE |
17 |
|
Contrast Agents for X-Ray |
18 |
|
Contrast Agents for Magnetic Resonance Imaging |
18 |
|
Contrast Agents for Ultrasound |
19 |
|
PET Radiopharmaceuticals |
19 |
|
TABLE 9 COMPOUNDS USED IN PET SCAN |
20 |
|
IMAGING EQUIPMENT |
20 |
|
X-RAY IMAGING SYSTEM |
20 |
|
FLUOROSCOPY EQUIPMENT |
21 |
|
COMPUTED TOMOGRAPHY SCANNER |
21 |
|
ULTRASOUND MACHINES |
22 |
|
Bedside Doppler |
23 |
|
Duplex Doppler |
23 |
|
Color Doppler |
23 |
|
Power Doppler |
23 |
|
MAGNETIC RESONANCE IMAGING SYSTEM |
24 |
|
Conventional MRI Units |
24 |
|
Short-bore MRI Units |
25 |
|
Open MRI Units |
25 |
|
Mobile MRI Units |
25 |
|
Dedicated Extremity/Head/Breast MRI units |
25 |
|
POSITRON EMISSION TOMOGRAPHY EQUIPMENT |
25 |
Chapter-4:
REGULATORY ASPECTS
|
COMPUTED TOMOGRAPHY |
26 |
|
ULTRASOUND |
27 |
|
POSITRON EMISSION TOMOGRAPHY |
27 |
|
NEED FOR CHANGE IN CURRENT GOOD MANUFACTURING PRACTICES REQUIREMENTS |
28 |
|
APPROVALS IN THE FIELD OF MEDICAL IMAGING |
28 |
|
TABLE 10 APPROVALS OF IMAGING AGENTS: 2006 THROUGH SEPTEMBER 2009 |
28 |
|
TABLE 11 APPROVALS OF IMAGING EQUIPMENT: 2006 THROUGH SEPTEMBER 2009 |
29 |
|
TABLE 12 RECALLS OF IMAGING REAGENTS: 2006 THROUGH SEPTEMBER 2009 |
29 |
|
TABLE 13 RECALLS OF IMAGING EQUIPMENT: 2006 THROUGH SEPTEMBER 2009 |
29 |
Chapter-5:
INDUSTRY STRUCTURE
|
MANUFACTURERS/ PRODUCTS FOR CONTRAST AGENTS/ IMAGING REAGENTS |
30 |
|
TABLE 14 LEADING MANUFACTURERS OF X-RAY AND COMPUTED TOMOGRAPGY CONTRAST AGENTS |
30 |
|
TABLE 15 LEADING MANUFACTURERS OF ULTRASOUND CONTRAST AGENTS |
31 |
|
TABLE 16 LEADING MANUFACTURERS OF MAGNETIC RESONANCE IMAGING CONTRAST AGENTS |
31 |
|
TABLE 17 LEADING MANUFACTURERS OF RADIOPHARMACEUTICALS |
32 |
|
MANUFACTURERS/ PRODUCTS FOR IMAGING SYSTEMS/ EQUIPMENT |
34 |
|
TABLE 18 LEADING MANUFACTURERS OF RADIOGRAPHY (X-RAY, FLUOROSCOPY AND MAMMOGRAPHY) IMAGING SYSTEMS |
34 |
|
TABLE 19 LEADING MANUFACTURERS OF COMPUTED TOMOGRAPHY SYSTEMS |
36 |
|
TABLE 20 LEADING MANUFACTURERS OF ULTRASOUND IMAGING SYSTEMS |
36 |
|
TABLE 21 LEADING MANUFACTURERS OF MAGNETIC RESONANCE IMAGING SYSTEMS |
39 |
|
TABLE 22 LEADING MANUFACTURERS OF POSITRON EMISSION TOMOGRAPHY SYSTEMS |
40 |
|
MARKET SHARES OF INDUSTRY LEADERS |
40 |
|
CONTRAST AGENTS/ IMAGING REAGENTS |
40 |
|
X-Ray and Computed Tomography Reagents |
40 |
|
TABLE 23 GLOBAL MARKET SHARES OF X-RAY AND COMPUTED TOMOGRAPHY CONTRAST AGENTS, 2009 (%) |
41 |
|
FIGURE 1 GLOBAL MARKET SHARES OF X-RAY AND COMPUTED TOMOGRAPHY CONTRAST AGENTS, 2009 (%) |
41 |
|
Ultrasound Contrast Agents |
42 |
|
TABLE 24 GLOBAL MARKET SHARES OF ULTRASOUND CONTRAST AGENTS, 2009 |
42 |
|
FIGURE 2 GLOBAL MARKET SHARES OF ULTRASOUND CONTRAST AGENTS, 2009 (%) |
42 |
|
Magnetic Resonance Imaging Agents |
43 |
|
TABLE 25 GLOBAL MARKET SHARES OF MAGNETIC RESONANCE IMAGING CONTRAST AGENTS, 2009 (%) |
43 |
|
FIGURE 3 GLOBAL MARKET SHARES OF MAGNETIC RESONANCE IMAGING CONTRAST AGENTS, 2009 (%) |
43 |
|
Radiopharmaceuticals |
44 |
|
TABLE 26 GLOBAL MARKET SHARES OF RADIOPHARMACEUTICALS, 2009 (%) |
44 |
|
FIGURE 4 GLOBAL MARKET SHARES OF RADIOPHARMACEUTICALS, 2009 (%) |
44 |
|
IMAGING SYSTEMS/ EQUIPMENT |
45 |
|
X-Ray Imaging Systems |
45 |
|
TABLE 27 GLOBAL MARKET SHARES OF X-RAY IMAGING SYSTEMS, 2009 (%) |
45 |
|
FIGURE 5 GLOBAL MARKET SHARES OF X-RAY IMAGING SYSTEMS, 2009 (%) |
45 |
|
Computed Tomography Imaging Systems |
46 |
|
TABLE 28 GLOBAL MARKET SHARES OF COMPUTED TOMOGRAPHY IMAGING SYSTEMS, 2009 (%) |
46 |
|
FIGURE 6 GLOBAL MARKET SHARES OF COMPUTED X-RAY IMAGING SYSTEMS, 2009 (%) |
46 |
|
Ultrasound Imaging Systems |
47 |
|
TABLE 29 GLOBAL MARKET SHARES OF ULTRASOUND IMAGING SYSTEMS, 2009 (%) |
47 |
|
FIGURE 7 GLOBAL MARKET SHARES OF ULTRASOUND IMAGING SYSTEMS, 2009 (%) |
47 |
|
Magnetic Resonance Imaging Systems |
48 |
|
TABLE 30 GLOBAL MARKET SHARES OF MAGNETIC RESONANCE IMAGING SYSTEMS, 2009 (%) |
48 |
|
FIGURE 8 GLOBAL MARKET SHARES OF MAGNETIC RESONANCE IMAGING SYSTEMS, 2009 (%) |
48 |
|
Positron Emission Tomography Imaging Systems |
49 |
|
TABLE 31 GLOBAL MARKET SHARES OF POSITRON EMISSION TOMOGRAPHY SYSTEMS, 2009 |
49 |
|
FIGURE 9 GLOBAL MARKET SHARES OF POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS, 2009 (%) |
49 |
Chapter-6: NEW
DEVELOPMENTS
|
ULTRASOUND |
50 |
|
TABLE 32 NEW DEVELOPMENTS IN THE FIELD OF ULTRASOUND IMAGING, 2007-2009 |
50 |
|
MAGNETIC RESONANCE IMAGING |
52 |
|
TABLE 33 NEW DEVELOPMENTS IN THE FIELD OF MAGNETIC RESONANCE IMAGING |
52 |
|
COMPUTED TOMOGRAPHY |
53 |
|
TABLE 34 NEW DEVELOPMENTS IN THE FIELD OF COMPUTED TOMOGRAPHY IMAGING |
53 |
|
X-RAY SYSTEMS |
54 |
|
TABLE 35 NEW DEVELOPMENTS IN THE FIELD OF X-RAY IMAGING |
54 |
|
POSITRON EMISSION TOMOGRAPHY |
54 |
|
TABLE 36 NEW DEVELOPMENTS IN THE FIELD OF POSITRON EMISSION TOMOGRAPHY IMAGING |
54 |
Chapter-7:
MARKETS
|
IMAGING REAGENTS/ CONTRAST AGENTS |
55 |
|
X-RAY AND CT CONTRAST AGENTS |
55 |
|
Market Overview |
55 |
|
Market Revenue |
56 |
|
TABLE 37 GLOBAL MARKET FOR X-RAY AND CT CONTRAST AGENTS BY REGION, THROUGH 2014 ($ MILLIONS) |
56 |
|
FIGURE 10 GLOBAL MARKET FOR X-RAY AND CT CONTRAST AGENTS BY REGION, 2007-2014 ($ MILLIONS) |
57 |
|
Market Shares |
57 |
|
TABLE 38 GLOBAL X-RAY AND CT CONTRAST AGENTS MARKET SHARES BY REGION, 2009 (%) |
58 |
|
FIGURE 11 GLOBAL X-RAY AND CT CONTRAST AGENTS MARKET SHARES BY REGION, 2009 (%) |
58 |
|
ULTRASOUND CONTRAST AGENTS |
58 |
|
Market Overview |
59 |
|
Market Revenue |
60 |
|
TABLE 39 GLOBAL MARKET FOR ULTRASOUND CONTRAST AGENTS BY REGION, THROUGH 2014 ($ MILLIONS) |
60 |
|
FIGURE 12 GLOBAL MARKET FOR ULTRASOUND CONTRAST AGENTS BY REGION, 2007-2014 ($ MILLIONS) |
60 |
|
Market Share |
61 |
|
TABLE 40 GLOBAL ULTRASOUND CONTRAST AGENTS MARKET SHARES BY REGION, 2009 (%) |
61 |
|
FIGURE 13 GLOBAL ULTRASOUND CONTRAST AGENTS MARKET SHARES BY REGION, 2009 (%) |
62 |
|
MRI CONTRAST AGENTS |
62 |
|
Market Overview |
62 |
|
Market Revenue |
64 |
|
TABLE 41 GLOBAL MARKET FOR MAGNETIC IMAGING RESONANCE CONTRAST AGENTS BY REGION, THROUGH 2014 ($ MILLIONS) |
64 |
|
FIGURE 14 GLOBAL MARKET FOR MAGNETIC RESONANCE IMAGING CONTRAST AGENTS BY REGION, 2007-2014 ($ MILLIONS) |
64 |
|
Market Share |
65 |
|
TABLE 42 GLOBAL MAGNETIC RESONANCE IMAGING CONTRAST AGENTS MARKET SHARES BY REGION, 2009 (%) |
65 |
|
FIGURE 15 GLOBAL MAGENTIC RESONANCE IMAGING CONTRAST AGENTS MARKET SHARES BY REGION, 2009 (%) |
65 |
|
RADIOPHARMACEUTICALS |
66 |
|
Market Overview |
66 |
|
Market Revenue |
67 |
|
TABLE 43 GLOBAL MARKET FOR RADIOPHARMACEUTICALS BY REGION, THROUGH 2014 ($ MILLIONS) |
67 |
|
FIGURE 16 GLOBAL MARKET FOR RADIOPHARMACEUTICALS BY REGION, 2007-2014 ($ MILLIONS) |
67 |
|
Market Share |
68 |
|
TABLE 44 GLOBAL RADIOPHARMACEUTICALS MARKET SHARES BY REGION, 2009 (%) |
68 |
|
FIGURE 17 GLOBAL RADIOPHARMACEUTICALS MARKET SHARES BY REGION, 2009 (%) |
68 |
|
IMAGING SYSTEMS/ EQUIPMENT |
69 |
|
X-RAY IMAGING SYSTEMS |
69 |
|
Market Overview |
69 |
|
Market Revenue |
70 |
|
TABLE 45 GLOBAL MARKET FOR X-RAY IMAGING SYSTEMS BY REGION, THROUGH 2014 ($ MILLIONS) |
70 |
|
FIGURE 18 GLOBAL MARKET FOR X-RAY IMAGING SYSTEMS BY REGION, 2007-2014 ($ MILLIONS) |
70 |
|
Market Share |
71 |
|
TABLE 46 GLOBAL X-RAY IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) |
71 |
|
FIGURE 19 GLOBAL X-RAY IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) |
71 |
|
COMPUTED TOMOGRAPHY IMAGING SYSTEMS |
72 |
|
Market Overview |
72 |
|
Market Revenue |
73 |
|
TABLE 47 GLOBAL MARKET FOR COMPUTED TOMOGRAPHY IMAGING SYSTEMS BY REGION, THROUGH 2014 ($ MILLIONS) |
73 |
|
FIGURE 20 GLOBAL MARKET FOR COMPUTED TOMOGRAPHY IMAGING SYSTEMS BY REGION, 2007-2014 ($ MILLIONS) |
73 |
|
Market Share |
74 |
|
TABLE 48 GLOBAL COMPUTED TOMOGRAPHY IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) |
74 |
|
FIGURE 21 GLOBAL COMPUTED TOMOGRAPHY IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) |
74 |
|
ULTRASOUND IMAGING SYSTEMS |
75 |
|
Market Overview |
75 |
|
Market Revenue |
76 |
|
TABLE 49 GLOBAL MARKET FOR ULTRASOUND IMAGING SYSTEMS BY REGION, THROUGH 2014 ($ MILLIONS) |
76 |
|
FIGURE 22 GLOBAL MARKET FOR ULTRASOUND IMAGING SYSTEMS BY REGION, 2007-2014 ($ MILLIONS) |
76 |
|
Market Share |
77 |
|
TABLE 50 GLOBAL ULTRASOUND IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) |
77 |
|
FIGURE 23 GLOBAL ULTRASOUND IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) |
77 |
|
MAGNETIC RESONANCE IMAGING SYSTEMS |
78 |
|
Market Overview |
78 |
|
Market Revenue |
79 |
|
TABLE 51 GLOBAL MARKET FOR MAGNETIC RESONANCE IMAGING SYSTEMS BY REGION, THROUGH 2014 ($ MILLIONS) |
79 |
|
FIGURE 24 GLOBAL MARKET FOR MAGNETIC RESONANCE IMAGING SYSTEMS BY REGION, THROUGH 2014 ($ MILLIONS) |
79 |
|
Market Share |
80 |
|
TABLE 52 GLOBAL MAGNETIC RESONANCE IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) |
80 |
|
FIGURE 25 GLOBAL MAGNETIC RESONANCE IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) |
80 |
|
POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS |
80 |
|
Market Overview |
81 |
|
Market Revenue |
82 |
|
TABLE 53 GLOBAL MARKET FOR POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS BY REGION THROUGH 2014 ($ MILLIONS) |
82 |
|
FIGURE 26 GLOBAL MARKET FOR POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS BY REGION, 2007-2014 ($ MILLIONS) |
82 |
|
Market Share |
83 |
|
TABLE 54 GLOBAL POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) |
83 |
|
FIGURE 27 GLOBAL POSITRON EMISSION TOMOGRAPHY IMAGING SYSTEMS MARKET SHARES BY REGION, 2009 (%) |
83 |
Chapter-8:
MARKET BY APPLICATIONS
|
MARKET SHARE OF APPLICATIONS |
84 |
|
TABLE 55 GLOBAL IMAGING MARKET SHARES, BY APPLICATION, 2009 (%) |
85 |
|
FIGURE 28 GLOBAL IMAGING MARKET SHARES, BY APPLICATION, 2009 (%) |
85 |
|
CARDIOVASCULAR DISEASE DIAGNOSIS |
85 |
|
MARKET REVENUE |
86 |
|
TABLE 56 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF CARDIOVASCULAR DISEASES, THROUGH 2014 ($ MILLIONS) |
86 |
|
FIGURE 29 GLOBAL REVENUE FOR IMAGING BEING USED FOR DIAGNOSIS OF CARDIOVASCULAR DISEASES, 2007-2014 ($ MILLIONS) |
87 |
|
MARKET SHARE |
87 |
|
TABLE 57 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF CARDIOVASCULAR DISEASES, 2009 (%) |
87 |
|
FIGURE 30 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF CARDIOVASCULAR DISEASES, 2009 (%) |
88 |
|
ONCOLOGY DISEASE DIAGNOSIS |
88 |
|
MARKET REVENUE |
89 |
|
TABLE 58 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF CANCER, THROUGH 2014 ($ MILLIONS) |
89 |
|
FIGURE 31 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF CANCER, 2007-2014 ($ MILLIONS) |
90 |
|
MARKET SHARE |
90 |
|
TABLE 59 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF CANCER, 2009 (%) |
90 |
|
FIGURE 32 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF CANCER, 2009 (%) |
91 |
|
CENTRAL NERVOUS SYSTEM DIAGNOSIS |
91 |
|
MARKET REVENUE |
92 |
|
TABLE 60 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF CENTRAL NERVOUS SYSTEM DISEASES, THROUGH 2014 ($ MILLIONS) |
92 |
|
FIGURE 33 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF CENTRAL NERVOUS SYSTEM DISEASES, 2007-2014 ($ MILLIONS) |
93 |
|
MARKET SHARE |
93 |
|
TABLE 61 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF CENTRAL NERVOUS SYSTEM DISEASES, 2009 (%) |
93 |
|
FIGURE 34 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF CENTRAL NERVOUS SYSTEM DISEASES, 2009 (%) |
94 |
|
GASTROINTESTINAL (GI) SYSTEM DIAGNOSIS |
94 |
|
MARKET REVENUE |
95 |
|
TABLE 62 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF GASTROINTESTINAL DISEASES, THROUGH 2014 ($ MILLIONS) |
95 |
|
FIGURE 35 GLOBAL REVENUE FOR IMAGING USED FOR DIAGNOSIS OF GASTROINTESTINAL DISEASES, 2007-2014 ($ MILLIONS) |
95 |
|
MARKET SHARE |
96 |
|
TABLE 63 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF GASTROINTESTINAL DISEASES, 2009 (%) |
96 |
|
FIGURE 36 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF GASTROINTESTINAL DISEASES, 2009 (%) |
96 |
|
OTHERS |
97 |
|
MARKET REVENUE |
97 |
|
TABLE 64 GLOBAL REVENUE FOR IMAGING BEING USED FOR DIAGNOSIS OF OTHER DISEASES, THROUGH 2014 ($ MILLIONS) |
97 |
|
FIGURE 37 GLOBAL REVENUE FOR IMAGING BEING USED FOR DIAGNOSIS OF OTHER DISEASES, 2007-2014 ($ MILLIONS) |
97 |
|
MARKET SHARE |
98 |
|
TABLE 65 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF OTHER DISEASES, 2009 (%) |
98 |
|
FIGURE 38 GLOBAL IMAGING SYSTEMS MARKET SHARES, FOR DIAGNOSIS OF OTHER DISEASES, 2009 (%) |
98 |
Chapter-9:
PATENT ANALYSIS
|
PATENT ANALYSIS |
99 |
|
PATENTS BY YEAR |
99 |
|
TABLE 66 NUMBER OF SIGNIFICANT PATENTS BY YEAR, 2005-2009 |
100 |
|
FIGURE 39 NUMBER OF SIGNIFICANT PATENTS BY YEAR, 2005-2009 (NUMBER) |
100 |
|
FIGURE 40 NUMBER OF SIGNIFICANT PATENTS BY CATEGORY, 2005-2009 (%) |
101 |
|
PATENTS BY TYPE |
101 |
|
TABLE 67 PATENTS BY TYPE FOR CONTRAST AGENTS, 2005-2009 (NUMBER) |
102 |
|
FIGURE 41 PATENTS BY TYPE OF CONTRAST AGENT, 2005-2009 (NUMBER) |
102 |
|
TABLE 68 PATENTS BY TYPE OF IMAGING SYSTEM, 2005-2009 (NUMBER) |
103 |
|
FIGURE 42 PATENTS BY TYPE OF IMAGING SYSTEM, 2005-2009 (NUMBER) |
103 |
|
PATENTS BY COMPANY |
103 |
|
TABLE 69 NUMBER OF U.S. PATENTS BY COMPANY FOR CONTRAST AGENTS, 2005-2009 (NUMBER) |
104 |
|
FIGURE 43 NUMBER OF U.S. PATENTS BY COMPANY FOR CONTRAST AGENTS, 2005-2009 (NUMBER) |
104 |
|
TABLE 70 NUMBER OF U.S. PATENTS BY COMPANY FOR IMAGING SYSTEMS, 2005-2009 |
105 |
|
FIGURE 44 NUMBER OF U.S. PATENTS BY COMPANY FOR IMAGING SYSTEMS, 2005-2009 |
106 |
|
PATENTS BY COUNTRY |
106 |
|
TABLE 71 NUMBER OF U.S. PATENTS BY COUNTRY FOR CONTRAST AGENTS, 2005-2009 |
107 |
|
FIGURE 45 NUMBER OF U.S. PATENTS BY COUNTRY FOR CONTRAST AGENTS, 2005-2009 |
107 |
|
TABLE 72 PATENT SHARES BY COUNTRY FOR CONTRAST AGENTS, 2005-2009 (%) |
108 |
|
FIGURE 46 PATENT SHARES BY COUNTRY FOR CONTRAST AGENTS, 2005-2009 (%) |
108 |
|
TABLE 73 NUMBER OF U.S. PATENTS BY COUNTRY FOR IMAGING SYSTEMS, 2005-2009 |
109 |
|
FIGURE 47 NUMBER OF U.S. PATENTS BY COUNTRY FOR IMAGING SYSTEMS, 2005-2009 |
109 |
|
TABLE 74 PATENT SHARES BY COUNTRY FOR IMAGING SYSTEMS, 2005-2009 (%) |
110 |
|
FIGURE 48 PATENT SHARES BY COUNTRY FOR IMAGING SYSTEMS, 2005-2009 (%) |
110 |
|
PATENTS BY ASSIGNEE |
110 |
|
TABLE 75 NUMBER OF PATENTS BY ASIGNEE TYPE FOR CONTRAST AGENTS, 2005-2009 |
111 |
|
FIGURE 49 NUMBER OF PATENTS BY ASSGINEE TYPE FOR CONTRAST AGENTS, 2005-2009 |
111 |
|
TABLE 76 PATENTS BY ASSIGMEE TYPE FOR IMAGING SYSTEMS, 2005-2009 |
112 |
|
FIGURE 50 PATENTS BY ASSIGNEE TYPE FOR IMAGING SYSTEMS, 2005-2009 |
112 |
Chapter-10:
CURRENT SITUATION OF IMAGING MARKET
|
CONTRAST AGENT MARKET SITUATION |
113 |
|
IMAGING SYSTEMS MARKET SITUATION |
113 |
|
FACTORS AFFECTING THE IMAGING MARKET |
116 |
|
REGULATORY ACTIONS |
116 |
|
AGING POPULATION |
116 |
|
COMPETITION |
116 |
|
TECHNOLOGICAL ADVANCEMENTS |
117 |
|
SETBACKS IN INDUSTRY |
117 |
Chapter-11:
COMPANY PROFILES
|
ALOKA CO. LTD. |
118 |
|
AMAG PHARMACEUTICALS INC. |
118 |
|
ANALOGIC CORPORATION |
119 |
|
BAYER HEALTHCARE PHARMACEUTICALS |
119 |
|
COVIDIEN |
120 |
|
ECHOSON SA (PL) |
121 |
|
ESAOTE S.P.A |
121 |
|
E-Z-EM INC |
122 |
|
FONAR CORPORATION |
122 |
|
GE HEALTHCARE MEDICAL DIAGNOSTICS |
123 |
|
GUERBET LLC |
124 |
|
HITACHI MEDICAL SYSTEMS AMERICA INC |
124 |
|
HOLOGIC INC |
125 |
|
IN VIVO CORPORATION |
125 |
|
LANTHEUS MEDICAL IMAGING |
126 |
|
BLDG. 200-2 |
126 |
|
MALLINCKRODT |
126 |
|
MDS NORDION |
127 |
|
MEDISON AMERICA INC |
127 |
|
MILLENIUM TECHNOLOGIES LTD. |
128 |
|
ONI MEDICAL SYSTEMS INC. |
128 |
|
PARADIGM MEDICAL INDUSTRIES |
129 |
|
PARAMED MEDICAL SYSTEMS INC. |
129 |
|
PHILIPS HEALTHCARE |
129 |
|
POSITRON CORPORATION |
130 |
|
SHIMADZU CORPORATION |
131 |
|
SIEMENS AG |
131 |
|
SONOSITE INC |
132 |
|
TELEMED LTD. |
133 |
|
TERASON ULTRASOUND |
133 |
|
TIME MEDICAL INC |
134 |
|
TOMTEC IMAGING SYSTEMS |
134 |
|
TOSHIBA AMERICA INC |
135 |
|
TRIAD ISOTOPES INC |
135 |
|
ULTRASONIX MEDICAL CORP. |
136 |
|
VOLCANO CORPORATION |
137 |
|
ZONARE MEDICAL SYSTEMS INC. |
137 |
|
APPENDIX: ABBREVIATIONS |
138 |
Warranty Information
Find Similar Products by Category
Currency Converter
Choose a currency below to display product prices in the selected currency.
Add to Wish List
Related Products
-
The World Market for Video Content Analysis USD $6,720.00 -
World Market for Ultrasound Imaging Equipment USD $6,970.00 -
Medical Imaging Production Yearbook USD $5,610.00
You Recently Viewed...
All prices are in USD. Copyright 2010 Electronics.ca Publications.
|
| About Us | Contact us | Ordering Information | RSS | Terms and Conditions | Privacy policy |
Electronics.ca™ is a global research network serving the industry, corporations and investment banks. |
